tradingkey.logo

BRIEF-Capricor Therapeutics Completes Submission Of Biologics License Application To The U.S. FDA For Deramiocel

ReutersJan 2, 2025 2:21 PM

- Capricor Therapeutics Inc CAPR.O:

  • CAPRICOR THERAPEUTICS COMPLETES SUBMISSION OF BIOLOGICS LICENSE APPLICATION TO THE U.S. FDA FOR DERAMIOCEL FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

  • CAPRICOR THERAPEUTICS - BLA SUBMISSION TRIGGERS $10 MILLION MILESTONE PAYMENT TO CAPRICOR FROM NIPPON SHINYAKU

Source text: ID:nGNXc1dPKT

Further company coverage: CAPR.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI